Cargando…
Liquid biopsy in non-small cell lung cancer—current status and future outlook—a narrative review
Lung cancer ranks first as the cause of cancer-associated deaths gobally. The American Cancer Society estimates for 228,820 new cases and 135,720 deaths from lung cancer in the United States for the year 2020. Targeted treatment options have rapidly emerged for non-small cell lung cancer (NSCLC) wit...
Autores principales: | Smolle, Elisabeth, Taucher, Valentin, Lindenmann, Jörg, Pichler, Martin, Smolle-Juettner, Freyja-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182706/ https://www.ncbi.nlm.nih.gov/pubmed/34164273 http://dx.doi.org/10.21037/tlcr-21-3 |
Ejemplares similares
-
Prediction of Postoperative Clinical Outcomes in Resected Stage I Non-Small Cell Lung Cancer Focusing on the Preoperative Glasgow Prognostic Score
por: Lindenmann, Joerg, et al.
Publicado: (2020) -
The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer
por: Smolle, Elisabeth, et al.
Publicado: (2019) -
Role of Tumor-Associated Neutrophils in the Molecular Carcinogenesis of the Lung
por: Taucher, Elisabeth, et al.
Publicado: (2021) -
The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer
por: Lindenmann, Joerg, et al.
Publicado: (2023) -
Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes
por: Taucher, Elisabeth, et al.
Publicado: (2022)